Even though more evidence is needed to better understand the role of CaD in other diabetes-related microangiopathies such as DN, recent findings have demonstrated a strong rationale for its use in reducing UAER and markers of inflammation as well as improving endothelial function. The gene discussed is CAD; the disease is diabetes mellitus.